Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Rhythm Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
RYTM
Nasdaq
8731
http://www.rhythmtx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
- May 9th, 2024 8:01 pm
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcript
- May 8th, 2024 2:51 pm
Rhythm Pharmaceuticals Inc (RYTM) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...
- May 8th, 2024 7:06 am
Q1 2024 Rhythm Pharmaceuticals Inc Earnings Call
- May 8th, 2024 2:34 am
Rhythm Pharmaceuticals Reports Q1 2024 Results: Revenue Growth Amidst Challenges
- May 7th, 2024 12:36 pm
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates
- May 7th, 2024 12:15 pm
Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
- May 7th, 2024 11:00 am
Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting
- May 6th, 2024 12:00 pm
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
- May 1st, 2024 2:01 pm
Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline
- Apr 30th, 2024 2:01 pm
Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology
- Apr 29th, 2024 10:30 pm
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Apr 24th, 2024 8:01 pm
Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
- Apr 14th, 2024 12:46 pm
Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?
- Apr 10th, 2024 10:40 am
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
- Apr 1st, 2024 12:00 pm
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
- Mar 25th, 2024 12:00 pm
Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)
- Mar 22nd, 2024 11:01 pm
Insider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Shares
- Mar 20th, 2024 5:49 am
Insider Sell: Chief Technical Officer Joseph Shulman Sells 15,515 Shares of Rhythm ...
- Mar 20th, 2024 5:49 am
Insider Sell: CFO Hunter Smith Sells 15,515 Shares of Rhythm Pharmaceuticals Inc (RYTM)
- Mar 20th, 2024 5:49 am
Scroll